Announcement
30 Sep 2024
In September 2024, US BARDA awarded a USD 21 million contract to Ossium Health to support a clinical trial of a bone marrow treatment for use in radiological or nuclear emergencies.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
30 Sep 2024
Revocation date:
No revocation date
Announced: 30 Sep 2024
State aid, unspecified
In force
On 30 September 2024, the Biomedical Advanced Research and Development Authority (BARDA) announced funding for Ossium Health to evaluate a bone marrow medical countermeasure. The contract supports the...
Sign in to see more
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70674
interventions
194
jurisdictions
Harmful Trade Policy Interventions: Medical Goods
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7348
interventions
152
jurisdictions
G7: Harmful Trade Policy Interventions
This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 13 Jan 2025
25542
interventions
38
jurisdictions
G20: Harmful Trade Policy Interventions
This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 15 Jan 2025
53997
interventions
121
jurisdictions